Earnings Release • Mar 9, 2017
Earnings Release
Open in ViewerOpens in native device viewer
London, 9 March 2017
| | ||||||
|---|---|---|---|---|---|---|
| | ||||||
| | ||||||
| RoE |
remains well above our minimum target | |||||
| BVPS +11.5%, driven by strong earnings EUR 74.61 |
||||||
| Investments | ||||||
| EUR 1,340 m. EBIT: |
EUR 343 m. | NII: RoI from AuM: |
||||
| Strong EBIT margin of 16.8% driven by favourable U/W result (C/R: 93.7%) Major losses of EUR 627 m. higher than 2015 but below expected level Premium development in line with selective underwriting approach |
RoI above full-year target of 2.9% Ordinary investment income current interest environment AuM increased by 6.2% |
|||||
| EUR 16,354 m. (-4.2%) EUR 14,418 m. (-1.2%) EUR 1,689 m. EUR 1,171 m. 13.7% EUR 3.50 + 1.50 230% Life & Health R/I EBIT in line with expectation; 2015 Strong profit contribution from financial solutions; technical result F/x-adj. GWP -4.3% mainly due to discontinuation of large-volume |
GWP in line with guidance (f/x adjusted -2.1%) NPE f/x-adj. growth of +1.0% Good performance in U/W result and net investment income EUR 1,550 m. 3.0% benefited from positive one-off effect remains at attractive level in view of from US mortality below expectation treaties |
| Dividend per share | in EUR | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Payout ratio: [38%] |
[-] | [35%] | [37%] | [42%] | [43%] | [40%] | [52%] | [50%] | [51%] |
| 4.75 | 5.00* | ||||||||
| 4.25 | 1.50 | ||||||||
| 1.25 | 1.50 | ||||||||
| 3.00 | 3.00 | ||||||||
| 2.30 | 2.10 | 2.30 | 2.10 | 0,40 | |||||
| 0,50 | 2.60 | 3.00 | 3.00 | 3.25 | 3.50 | ||||
| 1.80 | 1.80 | ||||||||
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
Dividend per share Special dividend per share
* Subject to consent of AGM
* After tax; target: 900 bps above 5-year rolling average of 10-year German government bond rate ("risk free")
| 2012 | 2013 | 2014 | 2015 | 2016 | 2012 - 2016 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | RoE | Rank | RoE | Rank | RoE | Rank | RoE | Rank | RoE | Rank | avg. RoE | Rank |
| Peer 5, Bermuda, Property & Casualty |
17.5% | 1 | 17.1% | 2 | 16.6% | 1 | 13.0% | 3 | 12.7% | 2 | 15.4% | 1 |
| Hannover Re | 15.4% | 3 | 15.0% | 3 | 14.7% | 2 | 14.7% | 1 | 13.7% | 1 | 14.7% | 2 |
| Peer 8, Bermuda, Property & Casualty |
15.9% | 2 | 18.0% | 1 | 13.7% | 3 | 9.5% | 7 | 10.0% | 5 | 13.4% | 3 |
| Peer 3, Switzerland, Composite |
13.4% | 5 | 13.7% | 4 | 10.5% | 7 | 13.7% | 2 | 10.6% | 3 | 12.4% | 4 |
| Peer 2, Germany, Composite |
12.6% | 6 | 12.5% | 5 | 11.3% | 5 | 10.2% | 6 | 8.3% | 7 | 11.0% | 5 |
| Peer 7, Bermuda Property & Casualty |
8.8% | 9 | 11.8% | 6 | 13.2% | 4 | 10.3% | 5 | 7.7% | 8 | 10.4% | 6 |
| Peer 6, France, Composite |
9.1% | 8 | 11.2% | 7 | 9.6% | 9 | 10.7% | 4 | 9.3% | 6 | 10.0% | 7 |
| Peer 1, US, Property & Casualty |
15.2% | 4 | 9.4% | 9 | 9.4% | 10 | 7.5% | 10 | 5.9% | 10 | 9.5% | 8 |
| Peer 4, US, Life & Health |
9.9% | 7 | 6.5% | 10 | 10.6% | 6 | 7.6% | 9 | 10.6% | 4 | 9.0% | 9 |
| Peer 9, Bermuda Property & Casualty |
4.9% | 10 | 10.0% | 8 | 10.4% | 8 | 7.7% | 8 | 6.8% | 9 | 8.0% | 10 |
List shows the Top 10 of the Global Reinsurance Index (GloRe) Data based on company data, own calculation
| Group figures in m. EUR | Q4/2015 | Q4/2016 | 2015 | 2016 |
|---|---|---|---|---|
| Gross written premium | 4,123 | 3,900 | 17,069 | 16,354 |
| Net premium earned | 3,763 | 3,651 | 14,593 | 14,418 |
| Net underwriting result | 167 | 71 | 94 | 116 |
| - Incl. funds withheld | 269 | 154 | 489 | 448 |
| Net investment income | 440 | 404 | 1,665 | 1,550 |
| - From assets under own mgmt. | 338 | 322 | 1,270 | 1,218 |
| - From funds withheld | 102 | 82 | 395 | 332 |
| Other income and expenses | (42) | 25 | (4) | 23 |
| Operating profit/loss (EBIT) | 565 | 500 | 1,755 | 1,689 |
| Interest on hybrid capital | (18) | (18) | (84) | (72) |
| Net income before taxes | 547 | 482 | 1,671 | 1,618 |
| Taxes | (158) | (84) | (456) | (391) |
| Net income | 389 | 398 | 1,215 | 1,226 |
| - Non-controlling interests | 24 | 17 | 64 | 55 |
| Group net income | 365 | 381 | 1,151 | 1,171 |
| Retention | 84.0% | 88.2% | 87.0% | 89.3% |
| EBIT margin (EBIT/Net premium earned) | 15.0% | 13.7% | 12.0% | 11.7% |
| Tax ratio | 29.0% | 17.5% | 27.3% | 24.2% |
| Earnings per share (in EUR) | 3.02 | 3.16 | 9.54 | 9.71 |
| Property & Casualty R/I in m. EUR | Q4/2015 | Q4/2016 | 2015 | 2016 | YTD |
|---|---|---|---|---|---|
| Gross written premium | 2,019 | 2,084 | 9,338 | 9,205 | GWP f/x adjusted -0.2%; growth mainly from structured R/I and US, reduced volume from |
| Net premium earned | 2,134 | 2,060 | 8,100 | 7,985 | China motor business and specialty lines NPE f/x-adjusted +0.0% |
| Net underwriting result incl. interest on funds withheld |
185 | 209 | 452 | 503 | Major losses of EUR 627 m. below budget Conservative reserving of the most recent U/Y |
| Combined ratio incl. interest on funds withheld |
91.3% | 89.9% | 94.4% | 93.7% | leads to positive run-off; confidence level of loss reserves largely stable |
| Net investment income from assets under own management |
268 | 253 | 925 | 877 | Satisfactory ordinary investment income |
| Other income and expenses | (48) | (15) | (36) | (40) | Other income and expenses within normal range, decreased positive f/x effects |
| Operating profit/loss (EBIT) | 405 | 447 | 1,341 | 1,340 | EBIT margin of 16.8% (2015: 16.6%), well above target (10%) |
| Tax ratio | 29.9% | 21.2% | 27.5% | 25.3% | Net income increased by 3.8% |
| Group net income | 264 | 336 | 915 | 950 | |
| Earnings per share (in EUR) | 2.19 | 2.79 | 7.58 | 7.88 |
| 2016: Combined Ratio vs. MtCR | EBIT | |||||||
|---|---|---|---|---|---|---|---|---|
| margin | ||||||||
| Target | North America* | 91.0% | 26.1% | |||||
| markets | Continental Europe* | 94.3% | 15.8% | |||||
| Marine | 38.5% | 73.5% | ||||||
| Aviation | 72.8% | 43.1% | ||||||
| Specialty | Credit, surety and political risks | 104.9% | 1.4% | |||||
| lines worldwide |
UK, Ireland, London market and direct |
95.6% | 25.0% | |||||
| Facultative R/I | 95.6% | 10.8% | ||||||
| Worldwide Treaty* R/I | 103.9% | 4.0% | ||||||
| Global R/I |
Cat XL | 55.9% | 56.0% | |||||
| Structured R/I and ILS | 97.3% | 7.8% | ||||||
| Total | 93.7% | 16.8% | ||||||
| 0% | 20% | 40% | 60% | 80% | 100% | 120% |
MtCR = Maximum tolerable Combined Ratio Combined Ratio
* All lines of Property & Casualty reinsurance except those stated separately
1,730 724 627 2008 2009 2010 2011 2012 2013 2014 2015 2016 Gross Net Expected large losses (net) Natural and man-made catastrophe losses in % of Property & Casualty premium 8 % 13% 5 % 14% 25% 9 % 9 % 7 % 8 % 9 % 6 % 11% 5 % 12% 16% 7 % 8 % 6 % 7 % 8 % Expected large losses (net) in m. EUR 428 450 500 530 560 625 670 690 825
* Up to 2011 claims over EUR 5 m. gross, from 2012 onwards claims over EUR 10 m. gross
| Catastrophe losses* in m. EUR | Date | Gross | Net |
|---|---|---|---|
| Earthquake, Taiwan | 6 Feb | 21.6 | 19.2 |
| Storm / Hail, USA | 10 - 16 Apr | 11.4 | 8.4 |
| Earthquake, Japan | 14 Apr | 21.7 | 20.3 |
| Earthquake, Ecuador | 16 - 17 Apr | 59.3 | 58.3 |
| Wildfires, Canada | 30 Apr - 5 May | 190.8 | 127.9 |
| Storm "Elvira", Germany, France | 27 - 28 May | 18.5 | 11.9 |
| Storm / Flood, China | 1 Jun - 31 Jul | 13.2 | 13.2 |
| Storm / Hail, Netherlands, Germany | 22 - 23 Jun | 18.2 | 9.2 |
| Hail, Canada | 30 Jul | 15.1 | 9.1 |
| Typhoon "Meranti", Taiwan, China | 13 - 14 Sep | 12.2 | 12.2 |
| Hurricane "Matthew" Caribbean, USA | 3 - 8 Oct | 91.3 | 70.3 |
| Earthquake, New Zealand | 13 Nov | 85.2 | 56.3 |
| 12 Natural catastrophes | 558.3 | 416.4 | |
| 4 Marine claims | 124.6 | 66.5 | |
| 4 Property claims | 116.0 | 97.3 | |
| 1 Aviation claim | 12.3 | 11.1 | |
| 1 Credit claim | 35.2 | 35.2 | |
| 22 Major losses | 846.5 | 626.6 |
* Natural catastrophes and other major losses in excess of EUR 10 m. gross
| Life & Health R/I in m. EUR | Q4/2015 | Q4/2016 | 2015 | 2016 | YTD |
|---|---|---|---|---|---|
| Gross written premium | 2,104 | 1,816 | 7,731 | 7,149 | GWP f/x adj. -4.3%, decrease in premium due to discontinued large-volume treaties in |
| Net premium earned | 1,628 | 1,591 | 6,492 | 6,432 | Australia and China; reduced volume from UK annuities; NPE f/x-adjusted growth +2.2% |
| Net underwriting result incl. interest on funds withheld |
83 | (55) | 35 | (55) | Negative impact from legacy US mortality business masks positive underlying trend |
| Net investment income from assets under own management |
68 | 67 | 334 | 331 | Ordinary investment income in line with expectation |
| Other income and expenses | 8 | 41 | 36 | 67 | Improved other income mainly driven by positive f/x effects and reduced LoC costs |
| Operating profit/loss (EBIT) | 159 | 53 | 405 | 343 | EBIT margins: |
| EBIT margin | 9.8% | 3.3% | 6.2% | 5.3% | • Financial solutions: 18.5% (target: 2%) |
| Tax ratio | 27.3% | 15.6% | 27.1% | 25.2% | • Longevity: 2.2% (target: 2%) • Mortality/Morbidity 3.4% (target: 6%) |
| Group net income | 112 | 44 | 290 | 253 | |
| Earnings per share (in EUR) | 0.93 | 0.37 | 2.40 | 2.10 |
1) Based on MCEV principles and post-tax reporting (in 2015 cost of capital already increased from 4.5% to 6% in line with Solvency II) 2) Based on Solvency II principles and pre-tax reporting
Equities, RE and realisations largely compensate for lower ordinary income from FIS
| in m. EUR | Q4/2015 | Q4/2016 | 2015 | 2016 | RoI |
|---|---|---|---|---|---|
| Ordinary investment income* | 351 | 317 | 1,273 | 1,171 | 2.9% |
| Realised gains/losses | 12 | 53 | 136 | 206 | 0.5% |
| Impairments/appreciations & depreciations |
(14) | (15) | (38) | (76) | -0.2% |
| Change in fair value of financial instruments (through P&L) |
10 | (3) | 1 | 26 | 0.1% |
| Investment expenses | (21) | (29) | (101) | (109) | -0.3% |
| NII from assets under own mgmt. | 338 | 322 | 1,270 | 1,218 | 3.0% |
| NII from funds withheld | 102 | 82 | 395 | 332 | |
| Total net investment income | 440 | 404 | 1,665 | 1,550 |
| Unrealised gains/losses of investments | 31 Dec 15 | 31 Dec 16 |
|---|---|---|
| On Balance-sheet | 1,146 | 1,355 |
| thereof Fixed income AFS | 636 | 728 |
| Off Balance-sheet | 497 | 509 |
| thereof Fixed income HTM, L&R | 411 | 370 |
| Total | 1,643 | 1,864 |
* Incl. results from associated companies
| Investment category | 31 Dec 16 |
|---|---|
| Fixed-income securities | 87% |
| - Governments | 28% |
| - Semi-governments | 17% |
| - Corporates | 33% |
| Investment grade | 28% |
| Non-investment grade | 4% |
| - Pfandbriefe, Covered Bonds, ABS | 9% |
| Equities | 4% |
| - Listed Equity | 2% |
| - Private Equity | 2% |
| Real estate/real estate funds | 5% |
| Others | 1% |
| Short-term investments & cash | 4% |
| Total market values in bn. EUR | 42.3 |
Economic view based on market values as at 31 December 2016 * Before real estate-specific costs
| Investment category | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Fixed-income securities | 92% | 90% | 90% | 87% | 87% |
| - Governments | 19% | 19% | 21% | 26% | 28% |
| - Semi-governments | 23% | 20% | 19% | 17% | 18% |
| - Corporates | 33% | 36% | 36% | 34% | 33% |
| Investment grade | 30% | 33% | 33% | 30% | 28% |
| Non-investment grade3 ) |
3% | 3% | 3% | 4% | 4% |
| - Pfandbriefe, Covered bonds, ABS | 17% | 15% | 14% | 10% | 2) 9% |
| Equities | 2% | 2% | 2% | 3% | 4% |
| - Listed equity | <1% | <1% | <1% | 1% | 2% |
| - Private equity | 2% | 2% | 2% | 2% | 2% |
| Real estate/real estate funds | 2% | 4% | 4% | 4% | 5% |
| Others3 ) |
1% | 1% | 1% | 1% | 1% |
| Short-term investments & cash | 3% | 4% | 4% | 5% | 4% |
| Total market values in bn. EUR | 32.5 | 32.2 | 36.8 | 39.8 | 42.3 |
1) Economic view based on market values without outstanding commitments for Private Equity and Alternative Real Estate as well as fixed-income investments
of EUR 1,036.8 m. (EUR 837.1 m.) as at 31 December 2016
2) Of which Pfandbriefe and Covered Bonds = 76.3%
3) Reallocation of High Yield Funds from "Others" to "Corporates – Non-investment grade"
| in m. EUR | 31.12.2016 economic |
31.12.2016 Solvency II |
31.12.2015 Solvency II |
|
|---|---|---|---|---|
| Available Economic Capital / Own Funds |
13,485 | 12,859* | 11,983 | |
| Confidence Level | 99.97% | 99.5% | 99.5% | 99.5% |
| Required Capital / Solvency Capital Requirements |
10,382 | 5,150 | 5,586 | 5,433 |
| Excess Capital |
3,103 | 8,335 | 7,273 | 6,549 |
| Capital Adequacy Ratio |
130% | 262% | 230% | 221% |
| Minimum Target Ratio (Limit) | 100% | 200% | 180% | 180% |
| Minimum Target Ratio (Threshold) | 110% | n/a | 200% | 200% |
* The figure is based on the Solvency II reporting as of 31 December 2016. The related audits are at present (not fully) completed.
| in m. EUR |
Available Capital |
Required Capital |
CAR |
|---|---|---|---|
| Internal Model at VaR 99.97% | 13,485 | 10,382 | 130% |
| -5,232 | |||
| Internal Model at VaR 99.5% |
13,485 | 5,150 | 262% |
| Haircut for Minority Interests1) |
-626 | ||
| 12,8592) | 5,150 | 250% | |
| Add-On, Standard Formula OpRisk |
+436 | ||
| Regulatory View at VaR 99.5% |
12,8592) | 5,586 | 230% |
1) Non-available minority interests mostly consist of non-controlling interests in E+S Rückversicherung AG
2) The figures are based on Solvency II reporting as of 31 December 2016. The related audits are at present (not fully) completed
As at 31 December 2016
1) Operational risk according to standard formula
2) Including differences stemming from diversification effects considered in the full internal model
Own funds largely dominated by Tier 1 capital supplemented by hybrid capital
As at 31 December 2016
1) Adjustments for technical provisions incl. risk margin
2) Foreseeable dividends and distributions refer to Hannover Rück SE dividend as well as dividends to minorities within Hannover Re Group
| Business group | Key figures | Strategic targets for 2016 |
2016 |
|---|---|---|---|
| Group | Return on investment1) | ≥2.9% | 3.0% |
| Return on equity2) | ≥9.9% | 13.7% | |
| Earnings per share growth (y-o-y) | ≥6.5% | 1.8% | |
| Value creation per share3) | ≥7.5% | 18.6% | |
| Property & Casualty R/I | Gross premium growth | 3% - 5%4) | -0.2% |
| Combined ratio | ≤96%5) | 93.7% | |
| EBIT margin6) | ≥10% | 16.8% | |
| xRoCA7) | ≥2% | 7.1% | |
| Life & Health R/I | Gross premium growth | 5% - 7%8) | -4.3% |
| Value of New Business (VNB)9) | ≥ EUR 220 m. | EUR 893 m. | |
| EBIT margin6) Financial solutions/Longevity | ≥2% | 9.4% | |
| EBIT margin6) Mortality/Morbidity | ≥6% | 3.4% | |
| xRoCA7) | ≥3% | 3.5% |
5) Incl. expected net major losses of EUR 825 m. 6) EBIT/net premium earned
9) Based on a cost of capital of 6% (until 2014: 4.5%)
1) Excl. effects from ModCo derivatives 2) After tax; target: 900 bps above 5-year average return of 10-year German government bonds
3) Growth in book value per share + paid dividend 4) On average throughout the R/I cycle; at unchanged f/x rates
7) Excess return on allocated economic capital 8) Organic growth only; annual average growth (5 years), at unchanged f/x rates
| Lines of business | Volume1) | Profitability2) | |
|---|---|---|---|
| Target markets |
North America3) | + | |
| Continental Europe3) | +/- | ||
| Specialty lines worldwide |
Marine | +/- | |
| Aviation | - | ||
| Credit, surety and political risks | +/- | ||
| UK, Ireland, London market and direct | +/- | ||
| Facultative reinsurance | + | ||
| Global reinsurance |
Worldwide treaty3) reinsurance | +/- | |
| Cat XL | - | ||
| Structured reinsurance and ILS | +/- |
1) In EUR, development in original currencies can be different
2) ++ = well above CoC; + = above CoC; +/- = CoC earned; - = below Cost of Capital (CoC)
3) All lines of business except those stated separately
| Reporting categories | Volume1) | Profitability2) | |
|---|---|---|---|
| Financial solutions |
Financial solutions | ++ | |
| Longevity | +/- | ||
| Risk solutions |
Mortality | +/- | |
| Morbidity | +/- |
1) In EUR 2) ++ = well above CoC; + = above CoC; +/- = CoC earned; - = below Cost of Capital (CoC)
Hannover Re Group
Dividend payout ratio4) 35% 40% (If comfortable level of capitalisation remains unchanged, this ratio will increase through payment of another special dividend)
2) Subject to no major distortions in capital markets and/or major losses in 2017 not exceeding the large loss budget of EUR 825 m.
1) At unchanged f/x rates
| Property & Casualty R/I | Life & Health R/I | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| in m. EUR | 2015 | 2016 | Δ | 2015 | 2016 | Δ | 2015 | 2016 | Δ |
| Gross written premium | 9,338 | 9,205 | -1.4% | 7,731 | 7,149 | -7.5% | 17,069 | 16,354 | -4.2% |
| Net premium earned | 8,100 | 7,985 | -1.4% | 6,492 | 6,432 | -0.9% | 14,593 | 14,418 | -1.2% |
| Net underwriting result | 432 | 479 | +10.8% | (340) | (363) | +6.7% | 94 | 116 | +23.6% |
| Net underwritung result incl. funds withheld | 452 | 503 | +11.2% | 35 | (55) | - | 489 | 448 | -8.3% |
| Net investment income | 945 | 901 | -4.7% | 709 | 639 | -9.9% | 1,665 | 1,550 | -6.9% |
| From assets under own management | 925 | 877 | -5.2% | 334 | 331 | -1.1% | 1,270 | 1,218 | -4.1% |
| From funds withheld | 20 | 24 | +19.2% | 375 | 308 | -17.8% | 395 | 332 | -15.9% |
| Other income and expenses | (36) | (40) | +10.6% | 36 | 67 | +86.9% | (4) | 23 | - |
| Operating profit/loss (EBIT) | 1,341 | 1,340 | -0.1% | 405 | 343 | -15.3% | 1,755 | 1,689 | -3.8% |
| Interest on hybrid capital | 0 | (0) | - | (0) | 0 | - | (84) | (72) | -15.0% |
| Net income before taxes | 1,341 | 1,340 | -0.1% | 405 | 343 | -15.3% | 1,671 | 1,618 | -3.2% |
| Taxes | (368) | (339) | -8.0% | (110) | (87) | -21.1% | (456) | (391) | -14.2% |
| Net income | 973 | 1,001 | +2.9% | 295 | 257 | -13.1% | 1,215 | 1,226 | +1.0% |
| Non-controlling interest | 58 | 51 | -11.8% | 6 | 4 | -33.3% | 64 | 55 | -13.7% |
| Group net income | 915 | 950 | +3.8% | 290 | 253 | -12.7% | 1,151 | 1,171 | +1.8% |
| Retention | 89.3% | 88.5% | 84.2% | 90.4% | 87.0% | 89.3% | |||
| Combined ratio (incl. interest on funds withheld) | 94.4% | 93.7% | 99.5% | 100.8% | 96.7% | 96.9% | |||
| EBIT margin (EBIT / Net premium earned) | 16.6% | 16.8% | 6.2% | 5.3% | 12.0% | 11.7% | |||
| Tax ratio | 27.5% | 25.3% | 27.1% | 25.2% | 27.3% | 24.2% | |||
| Earnings per share (in EUR) | 7.58 | 7.88 | 2.40 | 2.10 | 9.54 | 9.71 |
| Property & Casualty R/I | Life & Health R/I | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| in m. EUR | Q4/2015 | Q4/2016 | Δ | Q4/2015 | Q4/2016 | Δ | Q4/2015 | Q4/2016 | Δ |
| Gross written premium | 2,019 | 2,084 | +3.2% | 2,104 | 1,816 | -13.7% | 4,123 | 3,900 | -5.4% |
| Net premium earned | 2,134 | 2,060 | -3.5% | 1,628 | 1,591 | -2.3% | 3,763 | 3,651 | -3.0% |
| Net underwriting result | 181 | 204 | +12.5% | (15) | (132) | - | 167 | 71 | - |
| Net underwritung result incl. funds withheld | 185 | 209 | +13.1% | 83 | (55) | - | 269 | 154 | - |
| Net investment income | 272 | 258 | -5.0% | 166 | 144 | -13.2% | 440 | 404 | -8.3% |
| From assets under own management | 268 | 253 | -5.7% | 68 | 67 | -0.9% | 338 | 322 | -4.9% |
| From funds withheld | 4 | 5 | +39.3% | 98 | 77 | -21.8% | 102 | 82 | -19.5% |
| Other income and expenses | (48) | (15) | - | 8 | 41 | - | (42) | 25 | - |
| Operating profit/loss (EBIT) | 405 | 447 | +10.5% | 159 | 53 | - | 565 | 500 | -11.5% |
| Interest on hybrid capital | 0 | (0) | - | (0) | (0) | - | (18) | (18) | -0.2% |
| Net income before taxes | 405 | 447 | +10.5% | 159 | 53 | - | 547 | 482 | -11.8% |
| Taxes | (121) | (95) | - | (43) | (8) | - | (158) | (84) | - |
| Net income | 284 | 353 | +24.1% | 115 | 45 | -61.4% | 389 | 398 | +2.4% |
| Non-controlling interest | 20 | 16 | -20.6% | 4 | 1 | -83.8% | 24 | 17 | -30.1% |
| Group net income | 264 | 336 | +27.6% | 112 | 44 | -60.6% | 365 | 381 | +4.5% |
| Retention | 91.1% | 89.1% | 77.2% | 87.2% | 84.0% | 88.2% | |||
| Combined ratio (incl. interest on funds withheld) | 91.3% | 89.9% | 94.9% | 103.5% | 92.9% | 95.8% | |||
| EBIT margin (EBIT / Net premium earned) | 19.0% | 21.7% | 9.8% | 3.3% | 15.0% | 13.7% | |||
| Tax ratio | 29.9% | 21.2% | 27.3% | 15.6% | 29.0% | 17.5% | |||
| Earnings per share (in EUR) | 2.19 | 2.79 | 0.93 | 0.37 | 3.02 | 3.16 |
1) Japan 2% 2) CEE and Russia 2%
* All lines of business except those stated separately
| Portfolio | Scenario | Change in market value in m. EUR |
Change in OCI before tax in m. EUR |
|
|---|---|---|---|---|
| Equity (listed and private equity) | -10% | -169 | -169 | |
| -20% | -339 | -339 | ||
| +50 bps | -903 | -808 | ||
| Fixed-income securities | +100 bps | -1,760 | -1,575 | |
| Credit spreads | +50% | -865 | -832 | |
| -10% | -194 | -73 | ||
| Real estate | +10% | 194 | 44 |
As at 31 December 2016
| Governments | Semi governments |
Corporates | Pfandbriefe, Covered bonds, ABS |
Short-term investments, cash |
Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AAA | 76.8% | 65.7% | 1.0% | 67.1% | - | 45.8% | ||||||
| A A |
11.4% | 27.9% | 13.4% | 14.1% | - | 15.7% | ||||||
| A | 6.2% | 2.3% | 35.5% | 5.4% | - | 16.1% | ||||||
| BBB | 4.1% | 1.2% | 41.6% | 9.4% | - | 17.8% | ||||||
| <bbb< td=""> | 1.4% | 3.0% | 8.5% | 4.0% | - | 4.6% | </bbb<>1.4% | 3.0% | 8.5% | 4.0% | - | 4.6% |
| Total | 100.0% | 100.0% | 100.0% | 100.0% | - | 100.0% | ||||||
| Germany | 10.1% | 49.5% | 3.9% | 27.3% | 38.1% | 18.5% | ||||||
| UK | 5.4% | 2.7% | 7.8% | 9.4% | 3.6% | 6.1% | ||||||
| France | 1.9% | 2.3% | 7.8% | 7.0% | 1.0% | 4.5% | ||||||
| GIIPS | 1.2% | 0.9% | 4.6% | 4.2% | 0.0% | 2.6% | ||||||
| Rest of Europe | 4.4% | 15.9% | 16.7% | 23.4% | 2.7% | 12.7% | ||||||
| USA | 61.0% | 5.0% | 36.0% | 5.4% | 14.7% | 33.9% | ||||||
| Australia | 3.7% | 8.0% | 6.9% | 11.8% | 6.4% | 6.6% | ||||||
| Asia | 7.6% | 4.6% | 4.8% | 0.0% | 21.4% | 5.9% | ||||||
| Rest of World | 4.7% | 11.0% | 11.5% | 11.5% | 12.1% | 9.3% | ||||||
| Total | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | ||||||
| Total b/s values in m. EUR | 11,655 | 7,173 | 12,977 | 3,666 | 1,688 | 37,158 |
IFRS figures as at 31 December 2016
| 2015 | 4.4 |
|---|---|
| 2014 | 4.6 |
| 2013 | 4.4 |
| 2012 | 4.5 |
| 2011 | 4.2 |
Average hedged inflation levels:
| in m. EUR | Inflation-linked bonds: Change in market value through OCI |
|---|---|
| Inflation expectation*: +100 bps | +94 |
| Inflation expectation*: -100 bps | -87 |
| Inflation expectation*: +400 bps | +423 |
Nominal value of inflation-linked bonds
This presentation does not address the investment objectives or financial situation of any particular person or legal entity. Investors should seek independent professional advice and perform their own analysis regarding the appropriateness of investing in any of our securities.
While Hannover Re has endeavoured to include in this presentation information it believes to be reliable, complete and up-to-date, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such information.
Some of the statements in this presentation may be forward-looking statements or statements of future expectations based on currently available information. Such statements naturally are subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements.
This presentation serves information purposes only and does not constitute or form part of an offer or solicitation to acquire, subscribe to or dispose of, any of the securities of Hannover Re.
© Hannover Rück SE. All rights reserved. Hannover Re is the registered service mark of Hannover Rück SE.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.